Pharmaceutical Technology, September 2012 Issue (PDF)
Process Analytical Technology
Formulation Development Forum: Hydrogels for Long-Sustained Release
Researchers have developed injectable, reformable, and spreadable hydrogels capable of delivering sustained release of the proteins they contain for up to six months.
Regulation and Compliance
Q&A on GDUFA implementation with Aloka Srinivasan, PhD, a principal consultant with Parexel and former team leader in FDA's Office of Generic Drugs.
2,4,6-Tribromoanisole and 2,4,6-Trichloroanisole
A review of taints and odors in the pharmaceutical and consumer healthcare industries.
Early Development GMPs for Stability (Part IV)
IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development, with a focus on stability.
Joint Regulatory Conferences: The Ultimate Connection
PDA's strategic plan calls for maintaining valuable and effective relationships with global regulators.
Future Innovation in Drug Delivery
Advances in targeted drug delivery and customized release profiles are key industry goals.
Temperature-Controlled Shippers
Packaging and monitoring tools protect temperature-sensitive pharmaceuticals.
Technology Transfer: Protecting the True Public Interest
Ties between the biotechnology industry and university research are crucial.
Europe Hones in on Antitrust Violations
The European Commission remains vigilant in monitoring potential pay-to-delay deals.
Compliant or Contraband?
International trade can be great for business, but breaking border laws can put one in hot water.
Process Analytical Technology: Charting Progress in Data Analysis
Industry experts share perspectives on analytical instrumentation, methods, and data analysis.
Meeting Challenges in Asymmetric Synthesis
Industry and academia advance novel approaches for achieving enanioselectivity.
In the Spotlight September 2012
New product reviews for September 2012, featuring products for manufacturing.
The Macro View
The weak global economy adds to the challenges of bio/pharma companies and their suppliers.
Classifying Rouge Helps Define Remediation Procedures
Identifying and classifying rouge can help to determine CAPA.
USP Further Strengthens Quality Standards for Heparin
USP optimizes identification tests and impurities procedures.
Campaign Mounts to Curb Counterfeit Drugs
Import controls and risk strategies aim to promote quality and spur new drug development.
Report from Brazil September 2012
Brazil takes first steps towards gaining quality requirements for pharmaceutical excipients.
Correlating Product Lifecycle and Manufacturing Site Characteristics with Critical-to-Quality Product Deviations
MIT survey results address product and site characteristics that statistically correlate with quality performance.
Peer Reviewed: Numerical Simulation of Tablet Coating
The authors investigate the tablet-coating process using a combination of different simulation techniques.